Key result
Parkinson's disease was not associated with an increased risk of atrial fibrillation compared to matched controls, with no significant difference in the proportion of advanced interatrial block (OR 1.4).
Why the study?
Previous studies suggested that Parkinson's disease patients could have an increased risk of atrial fibrillation, but supporting data remained limited.
Does Parkinson's Disease increase the risk of atrial fibrillation based on p-wave predictors and clinical risk scores?
Case-Control (n=192)
Single-blind
No
Does Parkinson's Disease increase the risk of atrial fibrillation based on p-wave predictors and clinical risk scores?
Parkinson's disease does not appear to be associated with an increased risk of atrial fibrillation as assessed by electrocardiographic p-wave indices and clinical risk scores.
Background: Previous studies suggested that Parkinson's Disease (PD) patients could have an increased risk of atrial fibrillation. However, data supporting this association is not robust. We aimed to compare the potential risk of atrial fibrillation associated with PD in an age and gender matched case-control study, comparing the p-wave indexes from electrocardiograms and clinical risk scores among groups. Methods: A cross-sectional case-control study was performed. All subjects included in the analysis were clinically evaluated and subjected to a 12-lead electrocardiogram. Two blinded independent raters measured the p-wave duration. Subjects were classified as having normal P-wave duration (<120 ms), partial IAB (P-wave duration ≥ 120 ms, positive in inferior leads), and advanced IAB (p-wave duration ≥ 120 ms with biphasic morphology in inferior leads). Atrial fibrillation risk scores (CHARGE-AF, HATCH, and HAVOC) were calculated. Results: From 194 potential participants, three were excluded from the control group due to a previous diagnosis of atrial fibrillation. Comparing the PD patients ( n = 97) with controls ( n = 95), there were no statistically significant differences regarding the mean p-wave duration (121 ms vs. 122 ms, p = 0.64) and proportion of advanced interatrial block (OR = 1.4, 95%CI = 0.37–5.80, p = 0.58). All patients had a low or medium risk of developing atrial fibrillation based on the clinical scores. There were no differences between the PD patients and controls regarding the mean values of CHARGE-AF, HATCH, and HAVOC. Conclusions: Our results do not support the hypothesis that PD patients have an increased risk of atrial fibrillation based on the p-wave predictors and atrial fibrillation clinical scores.
No takes yet. Share an insight, caveat, or question.
Alves et al. (2021) conducted a case-control in Parkinson's Disease (n=192). Parkinson's Disease vs. Age- and gender-matched controls was evaluated on Advanced interatrial block (OR 1.4, 95% CI 0.37-5.80, p=0.58). Parkinson's disease was not associated with an increased risk of atrial fibrillation compared to matched controls, with no significant difference in the proportion of advanced interatrial block (OR 1.4).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: